29 related articles for article (PubMed ID: 9694535)
1. Cholesterol ester transfer protein and apolipoprotein E gene polymorphisms in hyperlipidemic Asian Indians in North India.
Meena K; Misra A; Vikram N; Ali S; Pandey RM; Luthra K
Mol Cell Biochem; 2011 Jun; 352(1-2):189-96. PubMed ID: 21380728
[TBL] [Abstract][Full Text] [Related]
2. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.
von Eckardstein A; Huang Y; Wu S; Funke H; Noseda G; Assmann G
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):691-703. PubMed ID: 7749883
[TBL] [Abstract][Full Text] [Related]
3. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL.
von Eckardstein A; Jauhiainen M; Huang Y; Metso J; Langer C; Pussinen P; Wu S; Ehnholm C; Assmann G
Biochim Biophys Acta; 1996 Jun; 1301(3):255-62. PubMed ID: 8664337
[TBL] [Abstract][Full Text] [Related]
4. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients.
von Eckardstein A; Huang Y; Kastelein JJ; Geisel J; Real JT; Kuivenhoven JA; Miccoli R; Noseda G; Assmann G
Atherosclerosis; 1998 May; 138(1):25-34. PubMed ID: 9678768
[TBL] [Abstract][Full Text] [Related]
5. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
[TBL] [Abstract][Full Text] [Related]
6. Lipoproteins containing apolipoprotein A-IV but not apolipoprotein A-I take up and esterify cell-derived cholesterol in plasma.
von Eckardstein A; Huang Y; Wu S; Sarmadi AS; Schwarz S; Steinmetz A; Assmann G
Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1755-63. PubMed ID: 7583553
[TBL] [Abstract][Full Text] [Related]
7. High density lipoproteins and reverse cholesterol transport: lessons from mutations.
von Eckardstein A; Assmann G
Atherosclerosis; 1998 Apr; 137 Suppl():S7-11. PubMed ID: 9694535
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein subclasses and apolipoprotein A-I.
Duriez P; Fruchart JC
Clin Chim Acta; 1999 Aug; 286(1-2):97-114. PubMed ID: 10511287
[TBL] [Abstract][Full Text] [Related]
9. High density lipoproteins, reverse transport of cholesterol, and coronary artery disease. Insights from mutations.
Assmann G; von Eckardstein A; Funke H
Circulation; 1993 Apr; 87(4 Suppl):III28-34. PubMed ID: 8462178
[TBL] [Abstract][Full Text] [Related]
10. High-density lipoprotein subpopulations in pathologic conditions.
Asztalos BF; Schaefer EJ
Am J Cardiol; 2003 Apr; 91(7A):12E-17E. PubMed ID: 12679198
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance.
Fruchart JC; Ailhaud G
Clin Chem; 1992 Jun; 38(6):793-7. PubMed ID: 1597003
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
